Unapproved gene therapy for boosting longevity is set to go on sale

Unapproved gene therapy for boosting longevity is set to go on sale. A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overseas clinics to bypass FDA rules

A apuração publicada por www.newscientist.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overseas clinics to bypass FDA rules

• Ponto de atenção: unapproved.
• Ponto de atenção: gene.
• Ponto de atenção: therapy.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Ciência.